Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
ID: 354980Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCCDPHP (HHS-CDC-NCCDPHP)

Award Range

$1M - $2M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to support national organizations in reducing the time to lupus diagnoses, improving care coordination, and enhancing the quality of life for individuals living with lupus, particularly among underserved populations. The program will focus on two key strategies: increasing healthcare provider awareness and promoting effective lupus self-management tools. The total estimated funding for this program is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are expected to be submitted by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Improving well-being for individuals living with a blood disorder through evidence-based programs.
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control - NCBDDD is offering a federal grant opportunity aimed at improving the well-being of individuals living with blood disorders through evidence-based programs. The initiative seeks to enhance the emotional, social, and physical health of affected individuals by promoting mental health literacy and adapting programs that build psychosocial skills, ultimately aiming to reduce morbidity and improve quality of life. With an estimated total program funding of $5,925,000, the agency plans to award four cooperative agreements, with individual awards ranging from $135,000 to $450,000. Interested applicants can reach out to Dr. Fiona Bethea at gvu0@cdc.gov or by phone at 404-639-4033, with applications due by May 15, 2025, and awards expected to be announced by September 1, 2025.
    Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)" through a cooperative agreement. This initiative aims to evaluate the effectiveness of existing Clinical Community Linkage (CCL) and social connectedness programs in reducing disparities related to diabetes risk factors, incidence, and complications, while also assessing the impact of various mechanisms on diabetes outcomes. The program is critical for informing future scaling of effective interventions and understanding the characteristics of successful programs, particularly for populations facing documented disparities. The estimated total program funding is $3,150,000, with an award ceiling of $350,000 and an expected three awards. Interested applicants must submit their proposals electronically by January 6, 2025, and can direct inquiries to Dr. Celeste Sanders at CSanders4@cdc.gov or by phone at 770-488-2536.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)." This initiative aims to support investigator-initiated research focused on identifying and evaluating potential risk factors associated with ALS, particularly those related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. The program is significant for advancing understanding of ALS and its risk factors, especially in diverse populations, including racial and ethnic minorities and military veterans. Interested applicants can apply for funding ranging from $0 to $500,000, with an estimated total program funding of $7.5 million available for approximately eight awards. Applications must be submitted electronically by November 4, 2024, and inquiries can be directed to Candis M. Hunter, PhD, MSPH, REHS, at ncipcerpo@cdc.gov.
    Advancing the Centers of Excellence in Newcomer Health
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Strengthening Vaccine-Preventable Disease Prevention and Response
    Active
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Strengthening Vaccine-Preventable Disease Prevention and Response," aimed at enhancing the nation's immunization infrastructure. This cooperative agreement will support the Immunization Services Division (ISD) in implementing critical programs, including Section 317 and the Vaccines for Children (VFC) Program, to improve vaccination coverage and response to public health threats. The initiative is vital for ensuring equitable access to vaccines, particularly for underserved populations, and will focus on seven priority strategies to strengthen program management and enhance vaccination readiness. The estimated total program funding is $2 billion, with 66 awards expected, and interested applicants can reach out to Randi Tolstyk at 770-488-5114 or via email at KKQ9@cdc.gov. Applications must be submitted electronically by March 7, 2025, with awards anticipated by June 27, 2025.
    Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement a protocol for managing urinary and kidney systems in young children with myelomeningocele. The program is critical for understanding health outcomes and improving care for this population, with an estimated total funding of $2,330,000, awarding between $166,428 and $488,571 to approximately 19 recipients. Interested small businesses can reach out to Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov for further details, with applications due by April 4, 2025, and project start anticipated in September 2025.
    Epilepsy Incidence Among Children in the United States
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Epilepsy Incidence Among Children in the United States," aimed at understanding the incidence of epilepsy among U.S. children aged 0 to 17 years. The primary objectives include estimating epilepsy incidence using comprehensive nationwide datasets, identifying risk factors associated with developing epilepsy, and examining disparities in incidence rates across various demographics and social determinants of health. This research is crucial for informing public health policies and resource allocation to improve healthcare services for affected populations. The estimated total program funding is $1.6 million, with a maximum award ceiling of $500,000, and interested applicants must submit their proposals by January 23, 2025. For further inquiries, contact Alison Amoroso at aamoroso@cdc.gov or call 470-395-2521.